HCC tissues; paired normal adjacent tissues; xenograft tumor tissues
MHCC97L; Huh7; SK-HEP-1; Hep3B; HCCLM3; LO2
cell line-derived xenograft
ERK (promotes); proliferation (promotes); cell cycle (promotes); migration (promotes); invasion (promotes); metastasis (promotes); ceRNA regulation (other)
RT-qPCR; ISH (In Situ Hybridization); FISH / smFISH; RNase R Treatment; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); Luciferase Reporter Assay; Transfection; CCK8; EdU Staining; Colony Formation Assay; Cell Cycle Assay; Transwell Assay; Wound Healing Assay; In Vivo Animal Model; H&E Staining; IHC (Immunohistochemistry); Western Blot; Survival Analysis; Bioinformatics Analysis
High hsa_circRNA_103809 expression is associated with lower overall survival and adverse clinicopathological features including vascular invasion, cirrhosis, tumor size, and Edmindson grade.
hsa_circRNA_103809 is up-regulated in HCC tissues and cell lines, and high expression predicts poorer survival. Functionally, it promotes HCC proliferation, cell cycle progression, migration, invasion, and xenograft tumor growth. Mechanistically, it binds and suppresses miR-377-3p, thereby increasing FGFR1 expression and affecting the FGFR1/ERK-related oncogenic program.
0.8457
Circular RNA hsa_circRNA_103809 promoted hepatocellular carcinoma development by regulating miR-377-3p/FGFR1/ERK axis.
combined biological and clinical study